Searchable abstracts of presentations at key conferences in endocrinology

ea0020oc4.2 | Acromegaly/IGF1/Type 2 Diabetes | ECE2009

Both insulin resistance and insulin secretion are involved in the pre-diabetes of acromegaly

Niculescu Dan , Purice Mariana , Lichiardopol Radu , Coculescu Mihail

In acromegalic patients growth hormone (GH) excess induces insulin resistance but whether this is sufficient, in the face of normal insulin secretion, for pre-diabetes (impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)) to occur is a matter of debate.Aim: To assess the relative role of insulin resistance and insulin secretion in the pre-diabetes of acromegaly.Methods: One hundred and twenty-four patients with acro...

ea0014p83 | (1) | ECE2007

Insulin resistance and insulin secretion in non-diabetic acromegalic patients

Niculescu Dan , Purice Mariana , Lichiardopol Radu , Coculescu Mihail

Aim: To set up, in acromegaly without diabetes mellitus, a correlation between the disease activity in GH-secreting adenoma (AA) - assessed by minimum GH serum level during an oral glucose tolerance test (OGTT) - and severity of insulin resistance (IR), assessed by HOMA-IR index.Methods: 75 out of 88 consecutive patients with acromegaly hospitalized in our department were included in this study. 13 patients proved to have diabetes mellitus and were exclu...

ea0011p633 | Neuroendocrinology and behaviour | ECE2006

Hormone therapy effects on sleep and dreams in menopausal women

Rasanu C , Niculescu D , Botusan I , Filip O , Coculescu M

Introduction and objective: This study aims to report if hormone therapy modifies sleep architecture and dreams in menopausal women. Women with no hormone therapy for flushes usually present sleep deprivation and daily sleepiness as a result of nocturnal arousals. Estrogen and progesterone brain receptors can influence memory and cognition processes. Dreams modulators are cognition, socio-cultural factors, personality and brain physiology (REM/NREM percents, circadian influenc...

ea0056p634 | Clinical case reports - Thyroid/Others | ECE2018

When it is the time of prophylactic thyroidectomy to children with medullary thyroid cancer with RET proto-oncogene Cys634Trp mutation in a family with multiple endocrine neoplasia type 2A

Galesanu Corina , Niculescu Dan , Apostu Luminita , Romeo Galesanu Mihail

Background: Almost all patients with Multiple Endocrine Neoplasia, type 2A (MEN 2A) have MTC. C-cell hyperplasia develops early in life and can be viewed as the precursor lesion for MTC. Children with MEN2A who have a total early thyroidectomy have an excellent chance of remaining disease-free.Objectives: To follow-up the children with RET mutation in a family with MEN2A.Methods: We report a family with MEN2A in which the first pat...

ea0081p247 | Late-Breaking | ECE2022

Long-term mortality and excess mortality after hip fracture in the main urban area of Romania

Dobre Ramona , Ruzandra Poiana Ioana , Alexandru Niculescu Dan , Cirstoiu Catalin , Popescu Gheorghe , Poiana Catalina

Background: Excess mortality after hip fracture remains a problem of public health concern. Until present, for Romania no data is available regarding long term mortality rate and excess mortality after hip fracture. We aimed to evaluate the mortality rate 3 years after hip fracture and also standardized mortality rates of osteoporotic hip fracture in the capital city of Romania and suburban area.Methods: we collected data from over 98 % of fractures admi...

ea0063p1099 | Pituitary and Neuroendocrinology 3 | ECE2019

Pituitary apoplexy (PA) – a relatively rare condition requiring early recognition, individualized treatment and longterm follow-up

Vladan Andreea , Baranga Iuliana , Niculescu Dan , Radian Serban , Radian Serban , Poiana Catalina

Background: PA is a clinical syndrome secondary to hemorrhage or infarction of pituitary tumour, presenting with sudden onset headache and oculomotor palsy. PA may be managed conservatively in patients without visual disturbances.Aim: To describe PA patients illustrating typical aspects and peculiarities.Results: Case 1, a 49 years old (yo) male, presented for loss of consciousness in the ER. MRI showed a giant pituitary tumour, wh...

ea0049ep980 | Pituitary - Clinical | ECE2017

Associated neoplasia in Romanian acromegalic patients

Silea Simona , Galoiu Simona , Dumitrascu Anda , Niculescu Dan , Baciu Ionela , Poiana Catalina

Introduction: Acromegaly has various complications that significantly alter patients’ lives, one of which is developing neoplasia, a subject of high interest in the scientific community during the last years but without any firm conclusions.Aim: The main objective of this paper was to verify if Romanian acromegalic patients are susceptible to developing neoplasia and what types of tumors are associated with acromegaly. Another purpose of the paper w...

ea0049ep1018 | Pituitary - Clinical | ECE2017

Disposition index in active acromegaly: A pilot study

Niculescu Dan Alexandru , Dusceac Roxana , Caragheorgheopol Andra , Popescu Nicoleta , Poiana Catalina

Background: Active acromegaly is characterized by decreased insulin sensitivity (ISen). However, insulin secretion (ISec) may not increase satisfactorily to compensate for the low ISen.Aim: To assess ISen and ISec and to calculate disposition index (DI) using an intravenous glucose tolerance test (IVGTT) in patients with active acromegaly.Methods: Twelve patients (7 men, 5 women) with active acromegaly and 2 normal subjects (2 men)...

ea0059p203 | Thyroid | SFEBES2018

Characterization of thyroid nodules in acromegalic patients

Trifanescu Raluca , Galoiu Simona , Niculescu Dan , Baciu Ionela , Capatina Cristina , Radian Serban , Poiana Catalina

Background: Thyroid nodules were reported with high prevalence in acromegalic patients.Patients and methods: 63 acromegalic patients (16 males and 47 females), aged at diagnosis 43.6±12.7 years were retrospectively reviewed. Median duration of acromegaly was 8 years. 25 patients were residents in iodine deficient areas. GH, IGF1, TSH, FT4 were measured by chemiluminescence (Liaison). Thyroid ultrasound was performed. In suspected nodules,...

ea0037ep1161 | Clinical Cases–Pituitary/Adrenal | ECE2015

Pasireotide - the last treatment option in Cushing's disease - case report

Galesanu Corina , Condrea Adrian , Niculescu Dan , Florescu Alexandru , Buzduga Catalin , Moisii Liliana , Ciubotaru Vasile

Introduction: The most common cause of Cushing’s disease is ACTH secreting tumours of the pituitary gland. It is associated with high morbidity and mortality. Pasireotide, a potential therapy, has a unique, broad somatostatin-receptor–binding profile, with high binding affinity for somatostatin-receptor subtype 5.Case report: We present the a 40-years-old man diagnosed in 2005 with Cushing’s Disease for which a left adrenalectomy was perfo...